
Understand OS and OOT investigations under FDA and MHRA guidelines. Learn phase one and phase two, retesting, resampling, outlier tests, and follow-up actions to prevent warning letters.
Investigate human errors in pharmaceuticals by distinguishing root causes from human error and applying regulatory guidance and corrective actions. Use Swiss cheese and gemba to reduce variability.
This video will help viewers to understand why training on the investigation process is required. Further, you will understand in brief about types of investigation tools and how to achieve compliance by recording the use of specific investigation tool/s. Also, the viewers will understand the common errors by some persons during the investigation.
The next lecture will help to understand about out- of specification(OOS) results, FDA requirements for OOS investigation, Phase 1 and Phase 2 investigations, some examples of FDA citations, common problems of OOS, Outlier tests, Retesting and Resampling considerations, and Practical examples of three sigma and six sigma for Out of trend evaluation
This next lecture will take you through understanding the consequences of Human errors, how to investigate human errors, and furthermore, the ways to reduce human errors. During this session, different models like the Swiss cheese model, and four quadrant models also will be discussed.
The next lecture will help you to learn about Good Review practices. This training will include, some examples of FDA citations, regulatory expectations about the review, 10 key principles about good review practices, how to qualify reviewers, and many more.
There is a small video lecture that will help viewers to understand Quality Risk Management principles, how it is simple and easy to implement, and achieve the compliance level. We have explained this with simple examples.